![Jay Kleiman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Kleiman
No open positions remaining
Health Technology
Profile
Jay Kleiman is Vice President of Northfield Laboratories, Inc. He was Chief Medical Officer and Head of Cardiovascular Development for Vasogen, Inc.
Former positions of Jay Kleiman
| Companies | Position | End |
|---|---|---|
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Corporate Officer/Principal | 10/11/2009 |
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Health Technology |
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
- Stock Market
- Insiders
- Jay Kleiman
